Ironwood Pharmaceuticals Inc’s recently made public that its Chief Executive Officer MCCOURT Thomas A unloaded Company’s shares for reported $0.24 million on Feb 10 ’25. In the deal valued at $1.76 per share,139,064 shares were sold. As a result of this transaction, MCCOURT Thomas A now holds 1,160,634 shares worth roughly $2.09 million.
Then, Silver Ronald sold 12,048 shares, generating $21,204 in total proceeds. Upon selling the shares at $1.76, the Principal Accounting Officer now owns 279,655 shares.
Before that, Shetzline Michael sold 41,269 shares. Ironwood Pharmaceuticals Inc shares valued at $72,633 were divested by the SVP, CMO, Head-Res&Drug at a price of $1.76 per share. As a result of the transaction, Shetzline Michael now holds 554,007 shares, worth roughly $1.0 million.
Leerink Partners initiated its Ironwood Pharmaceuticals Inc [IRWD] rating to a Market perform in a research note published on September 09, 2024; the price target was $5. A number of analysts have revised their coverage, including CapitalOne’s analysts, who decreased its forecast for the stock in early August from “an Overweight” to “an Equal weight”. Craig Hallum began covering IRWD with “Buy” recommendation on January 17, 2024. Wells Fargo started covering the stock on December 14, 2023. It rated IRWD as “an Overweight”.
Price Performance Review of IRWD
On Friday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock fall -0.83% to $1.80. Over the last five days, the stock has lost -6.25%. Ironwood Pharmaceuticals Inc shares have fallen nearly -59.37% since the year began. Nevertheless, the stocks have fallen -88.11% over the past one year. While a 52-week high of $15.26 was reached on 01/07/25, a 52-week low of $1.59 was recorded on 02/10/25. SMA at 50 days reached $3.3056, while 200 days put it at $4.7280.
Levels Of Support And Resistance For IRWD Stock
The 24-hour chart illustrates a support level at 1.7447, which if violated will result in even more drops to 1.6895. On the upside, there is a resistance level at 1.8526. A further resistance level may holdings at 1.9053. The Relative Strength Index (RSI) on the 14-day chart is 27.87, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0835, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.39%. Stochastics %K at 33.44% indicates the stock is a holding.
The most recent change occurred on November 09, 2023 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.
